Production (Stage)
MediciNova, Inc.
MNOV
$1.41
$0.01991.43%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -32.71% | -28.91% | -8.20% | 34.38% | 38.17% |
| Total Depreciation and Amortization | -2.78% | 4.43% | 12.57% | 22.91% | 24.14% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 99.48% | 35.39% | -36.19% | -54.13% | -41.88% |
| Change in Net Operating Assets | -88.22% | -974.64% | 106.94% | 12.97% | -3,492.06% |
| Cash from Operations | -30.00% | -43.22% | 15.80% | 30.42% | 34.29% |
| Capital Expenditure | 95.77% | 95.77% | 96.58% | 84.75% | -326.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -100.00% | 100.00% | 100.00% |
| Cash from Investing | 96.71% | -100.00% | -100.01% | 96.19% | 71.97% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | -- | -- | -- | -- |
| Foreign Exchange rate Adjustments | -136.28% | -76.88% | -143.29% | -40.87% | 413.89% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -30.13% | -132.74% | -822.76% | 30.90% | 34.70% |